OGI

Organigram Global Stock Analysis

AI Rating

Neutral
  • Quality7/10
  • Growth↑ 6/10
  • Momentum↓ 4/10
Organigram Global sales and earnings growth
OGI Growth
Good
  • Revenue Y/Y↑ 68.55%
  • EPS Y/Y↑ 123.23%
  • FCF Y/Y↓ -187.12%
Organigram Global gross and profit margin trends
OGI Profitability
Good
  • Gross margin ↑ 35.60%
  • EPS margin↓ 6.50%
  • ROIC↓ 1.60%
Organigram Global net debt vs free cash flow
OGI Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Organigram Global stock volatility is in-line with the overall market. We give it a Great risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗